BeOne Medicines Ltd.
BeOne Medicines Ltd. (ONC) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
onc · stock forecast · 14 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 14 Wall Street analysts in the past 3 months
Buy
14 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$436
Consensus
$399
+47.3% upside
Low
$340
Median: $409 · Last Close: $270.97
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$399.11
47.3% upside
High Target
$436
60.9%
Low Target
$340
25.5%
Current Price
$270.97
as of today
Based on analyst price targets, the ONC stock price prediction for the next 12 months ranges from $340 to $436. The consensus ONC price forecast of $399.11 implies 47.3% upside from the current price of $270.97.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $258.77 | ↓ 4.50% |
1-day model range: $257.75–$259.78. Peak: $259.78 (-4.50%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $305 | +12.7% |
| 2028 | $330 | +21.9% |
| 2029 | $348 | +28.4% |
| 2030 | $360 | +32.9% |
| 2031 | — | +35.9% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ONC · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-02 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-05-15 | Leerink Partners | Maintains | Outperform→Outperform |
| 2026-05-07 | Guggenheim | Maintains | Buy→Buy |
| 2026-05-07 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-05-07 | Barclays | Maintains | Overweight→Overweight |
| 2026-05-07 | Truist Securities | Maintains | Buy→Buy |
| 2026-03-16 | Jefferies | Downgrade ↓ | Buy→Hold |
| 2026-02-27 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-02-27 | Guggenheim | Maintains | Buy→Buy |
| 2026-02-27 | Barclays | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on BeOne Medicines Ltd. (ONC) stock. Of the recent 38 rating actions, 0 were upgrades and 1 were downgrades. 14 analysts currently cover ONC.
Analyst Recommendation Trends
ONC analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$6.5B
↓ 23.5% YoY
Revenue Next Year
$7.5B
↑ 15.4% YoY
EPS This Year
$6.73
EPS Next Year
$9.79
↑ 45.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast ONC EPS of $6.73 for the current fiscal year, based on estimates from 12 analysts. The ONC revenue forecast is $6.5B for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ONC stock forecast is supported by two independent data sources: analyst consensus ratings from 14 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ONC price target is $399.11 (+47.3% upside), with an analyst consensus of Buy.
The ONC short-term stock prediction for tomorrow is $258.77 (-4.50%). The ONC stock price prediction for 2027 estimates an average of $305. The ONC stock prediction for 2030 projects a range of $345–$376.
BeOne Medicines Ltd. trades on NASDAQ under the ticker ONC. The ONC stock outlook for 2027 is broadly positive, supported by a Buy consensus among 93% of covering analysts.
Frequently asked questions
ONC forecast · 8 questionsAccording to 14 Wall Street analysts, the average 12-month ONC price target is $399.11, with a high forecast of $436.00 and a low of $340.00. The median price target is shown in the chart above when available. This implies +47.3% potential upside from the current price of $270.97.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.